ICU Research And Ddevelopement To Revenue from 2010 to 2024
| ICUI Stock | USD 171.96 2.85 1.63% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.03777744 | Current Value 0.0262 | Quarterly Volatility 0.00773835 |
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 263.2 M, Interest Expense of 107.9 M or Total Revenue of 2.4 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
ICU | Research And Ddevelopement To Revenue |
Latest ICU Medical's Research And Ddevelopement To Revenue Growth Pattern
Below is the plot of the Research And Ddevelopement To Revenue of ICU Medical over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. ICU Medical's Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
| Research And Ddevelopement To Revenue | 10 Years Trend |
|
Research And Ddevelopement To Revenue |
| Timeline |
ICU Research And Ddevelopement To Revenue Regression Statistics
| Arithmetic Mean | 0.04 | |
| Geometric Mean | 0.04 | |
| Coefficient Of Variation | 20.22 | |
| Mean Deviation | 0.01 | |
| Median | 0.04 | |
| Standard Deviation | 0.01 | |
| Sample Variance | 0.00006 | |
| Range | 0.0331 | |
| R-Value | (0.26) | |
| Mean Square Error | 0.00006 | |
| R-Squared | 0.07 | |
| Significance | 0.35 | |
| Slope | (0.0004) | |
| Total Sum of Squares | 0.0008 |
ICU Research And Ddevelopement To Revenue History
About ICU Medical Financial Statements
Investors use fundamental indicators, such as ICU Medical's Research And Ddevelopement To Revenue, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Research And Ddevelopement To Revenue | 0.04 | 0.03 |
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out the analysis of ICU Medical Correlation against competitors. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (2.92) | Revenue Per Share 96.302 | Quarterly Revenue Growth 0.065 | Return On Assets 0.0066 |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.